CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Top UK Stocks to Watch IHG expects recovery to gain momentum

Article By: ,  Former Market Analyst

Top UK Stocks and Shares | IHG Share Price | IAG Share Price | St Modwen Share Price

Top News: IHG sees pick-up in demand in Americas and China

InterContinental Hotels Group said it saw a significant improvement in demand in March and April, led by improvements in the Americas and China, and said it expects momentum to build this year as the world comes out of the pandemic and ease restrictions.

The company said revenue per available room was down 34% in the first quarter from the year before and less than half what was delivered before the pandemic hit, but said it still outperformed its rivals in its key markets. IHG said occupancy continued to improve during the quarter but still only sat at 40%.

Virtually all of IHG’s sites are open, with just 4% of its estate currently shut.

In the Americas, occupancy levels improved to 46% in the first quarter from 42% in the final three months of 2020, but still remained well below pre-pandemic levels. Revenue per available room was down 40% from pre-pandemic levels.

In China, occupancy of 40% was far worse than the 57% seen in the previous quarter but revenue per available room improved and was more than 78% higher than the year before.

In Europe, the Middle East and Africa, occupancy came in at just 27% compared to 29% in the previous quarter and revenue per available room was 62% lower year-on-year and over 71% lower than before the pandemic hit.

‘Trading continued to improve during the first quarter of 2021, with IHG maintaining its outperformance of the industry in key markets and seeing strong performance in openings and signings as we expand our brands around the world. There was a notable pick-up in demand in March, particularly in the US and China, which continued into April. While the risk of volatility remains for the balance of the year, there is clear evidence from forward bookings data of further improvement as we look to the months ahead,’ said chief executive Keith Barr.

Industries that rely on travel, whether that be airlines or hotels, have been among the hardest hit by the pandemic but the outlook has improved significantly in recent months. For example, the EU has signalled it could start welcoming vaccinated visitors again as soon as next month while the UK is set to publish its finalised list of green travel countries later this month.  

 ‘As the rollout of vaccines becomes more established, travel restrictions lift, and economic activity rebuilds, traveller demand will continue to grow and generate further momentum in an industry recovery over the course of the year. Coupled with our resilience as a business and the important work we're doing to support our owners, develop our brands and expand our pipeline, we're confident that IHG is well positioned for sustained growth,’ he added.

Where next for the IHG share price?

IHG is trading above its ascending trendline dating back to early April last year. The rally has run out of steam in recent weeks, struggling to push past 5340p resistance. The price trades below its 20 & 50 EMA on the daily chart. The RSI has turned lower indicative of further downside. 

Immediate support is being tested at 5020 the ascending trendline. A break below here could see the sellers gain traction towards 4780p April’s low. 

On the upside, a move over the 20 & 50 EMAs at 5080 and 5100 could help the case for the bulls as they target 5340 for a break out move. 

IAG calls for travel corridors and digital vaccine passports

International Consolidated Airlines has urged governments to open travel corridors and get international travel back up and running to aid the global economic recovery as passenger numbers remain severely depressed due to restrictions.

IAG, which owns airlines including British Airways, Iberia and Vueling, said it was running at less than one-fifth of the capacity in the first quarter of 2021 compared to a year earlier and that it only expects this to improve to 25% in the second quarter, adding it is cautious about that forecast due to the ongoing uncertainty.  

The one bright spot in the period was a rise in cargo-only flights to 1,306 in the three-month period compared to only 969 in the fourth quarter of 2020.

Unsurprisingly, revenue was down almost 79% to EUR986 million from EUR4.58 billion the year before, with its adjusted operating loss ballooning to EUR1.13 billion from EUR535 million. The loss was slightly larger than the EUR1.12 billion loss forecast by analysts.

IAG said it is ‘ready to fly’ but stressed that it needs governments to take action. It is pushing for countries like the UK and the US, both of which are enjoying more successful vaccination campaigns than most countries, to open travel corridors for those who have had their jabs.

It also wants a cheaper and simpler quarantine system for arrivals, an improvement in contactless technology at the border and the introduction of digital passes to show if someone has been tested or vaccinated.

‘These measures will enable a safe re-opening of our skies. Travel underpins a global industry that supports 13 million jobs in Europe alone. There's a high level of pent-up demand and aviation will play a critical role in reconnecting people and getting economies back up and running again,’ IAG said.

IAG is not providing guidance due to the uncertain outlook, but said it ended the quarter with EUR10.5 billion of liquidity and had cut weekly operating costs to EUR175 million.

IAG shares were trading 0.3% higher in early trade this morning at 206.7.

St Modwen Properties backs possible takeover offer

St Modwen Properties said investment funds managed by the Blackstone Group have made a non-binding takeover offer for the company that it plans to recommend if it is finalised.

The property developer said Blackstone has made a ‘series of unsolicited proposals’ and that its latest offer is for 542 pence per share, more than a 21% premium to St Modwen’s closing share price yesterday. It is also almost 24% higher than its last reported net tangible assets per share figure of 438p.

The news sent St Modwen shares 19.5% higher in early trade this morning to 532.5 pence.

‘Having considered the possible offer, the board of St Modwen has indicated to Blackstone that the possible offer is at a value the board would be willing to recommend unanimously, should a firm intention to make an offer pursuant to Rule 2.7 of the Code be announced on such terms,’ St Modwen confirmed.

St Modwen intends to release another statement when appropriate.

The company has performed well during the pandemic thanks to its focus on investing in logistics and housebuilding, both of which have held up well and benefit from long-term structural growth.

AstraZeneca sees positive results after combining treatments for lung cancer

AstraZeneca said a trial combining imfinzi, tremelimumab and chemotherapy in patients with lung cancer demonstrated an improvement in survival rates compared to using chemotherapy alone.

The Phase III trial of imfinzi, tremelimumab and chemotherapy in people needing first line treatment for stage four non-small cell lung cancer ‘demonstrated a statistically significant and clinically meaningful overall survival benefit versus chemotherapy alone.’

‘We were particularly pleased by the safety profile. We've seen encouraging uptake of novel combinations in this setting and believe this new approach will add a further option for patients with high unmet medical need. We look forward to discussing next steps with regulatory authorities,’ said Dave Fredrickson, vice president of AstraZeneca’s oncology business.

However, trials that just used imfinzi and chemotherapy as a treatment did not deliver a statistically significant improvement in survival.

AstraZeneca shares were trading 0.7% higher this morning at 7719.5.

IPO News: Taylor Maritime, Liontrust ESG and Belluscura

There was plenty of news from companies planning to list on the London Stock Exchange over the coming weeks.

Taylor Maritime, which owns and operates ships used for dry bulk shipping, said it is issuing 250 million shares at $1 each to fund its proposed purchase of 23 ships. All the proceeds will be used to buy the ships and shares will be issued in the company to settle the difference. Notably, 17 of the 23 ships are already being managed by Taylor Maritime. The company said shares will start trading on the premium segment of the main market of the LSE on May 27. It said it should start life as a publicly-listed company with a net asset value of at least $0.98.

Meanwhile, Liontrust ESG also announced it plans to list on the premium segment of the main market by raising £150 million. The company plans to invest the funds in a number of ‘sustainable companies’ and plans to have 25 to 35 investments on its books at any one time. The initial fundraise is expected to close in late June with admission to occur soon after.

Lastly, Belluscura has outlined plans to list on AIM through a £15 million listing priced at 42 pence to 48 pence per share. The company has developed portable oxygen enrichment technology and its first product is a lightweight oxygen concentrator that has been cleared by the US Food & Drug Administration and used instead of much heavier tanks and devices. The listing is expected to complete before the end of May.

How to trade top UK stocks

You can trade a wide variety of UK stocks with City Index. Follow these easy steps to start trading the opportunities with UK stocks.

  1. Open a City Index account, or log-in if you’re already a customer.
  2. Search for the company you want to trade in our award-winning platform
  3. Choose your position and size, and your stop and limit levels
  4. Place the trade 

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.

© City Index 2024